Nuwellis Inc vs SailPoint Inc. Common Stock — how do they compare? Nuwellis Inc trades at $0.55 (market cap $2.00M), while SailPoint Inc. Common Stock trades at $19 (market cap $11.06B). The key difference: SailPoint Inc. Common Stock is far larger — about 5530× Nuwellis Inc's market cap, and SailPoint Inc. Common Stock is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 27 Days and SailPoint Inc. Common Stock for 0 Days on average.
| NUWE | SAIL | |
|---|---|---|
Market Cap | $2.00M | $11.06B |
Volume | 172,259 | 3,269,663 |
Sector | Health | Technology |
52-Week High | $146.65 | $22.85 |
52-Week Low | $0.53 | $10.49 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | -$1.72M | $10.76B |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.621, down 7.35% today, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth with 2026 revenue reaching $9M, but continues to post significant losses with a -125.63% net income margin. Recent positive developments include strong Aquadex console adoption and expanded pediatric footprint, though cash flow remains negative requiring ongoing financing.
The outlook remains challenging with persistent losses and negative cash flow offset by promising commercial momentum. Investment opportunity hinges on the company's ability to achieve profitability while risks include execution challenges and dependence on financing. Analyst sentiment is mixed with equal buy/hold ratings reflecting the high-risk, high-reward nature of this medical technology stock.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →